ASX - By Stock
|
MSB |
Re:
Ann: CEO Presentation to 2023 Annual General Meeting
|
|
Wazza222
|
114 |
36K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
114
|
36K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Financial Results on Form 6-K
|
|
Wazza222
|
1 |
1.3K |
26 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
1
|
1.3K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Wazza222
|
70 |
31K |
8 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
70
|
31K
|
8
|
|
ASX - By Stock
|
PLS |
Re:
lithium price in freefall!!!
|
|
Wazza222
|
102 |
55K |
1 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
102
|
55K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
Wazza222
|
778 |
282K |
2 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
778
|
282K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Transcatheter Cardiovascular Therapeutics Conference
|
|
Wazza222
|
33 |
12K |
1 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
33
|
12K
|
1
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
Wazza222
|
248 |
105K |
7 |
16/09/22 |
16/09/22 |
Charts
|
248
|
105K
|
7
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
Wazza222
|
248 |
105K |
0 |
16/09/22 |
16/09/22 |
Charts
|
248
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Wazza222
|
256 |
108K |
4 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
256
|
108K
|
4
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Site Operations Update
|
|
Wazza222
|
43 |
22K |
67 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
43
|
22K
|
67
|
|
ASX - By Stock
|
GRE |
Re:
Ann: Becoming a substantial holder
|
|
Wazza222
|
18 |
4.9K |
0 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
18
|
4.9K
|
0
|
|
ASX - By Stock
|
GRE |
Re:
Ann: Becoming a substantial holder
|
|
Wazza222
|
18 |
4.9K |
1 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
18
|
4.9K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Cheap TO in the making
|
|
Wazza222
|
23 |
11K |
14 |
07/05/22 |
07/05/22 |
ASX - By Stock
|
23
|
11K
|
14
|
|
Charts
|
AVZ |
Re:
AVZ chart
|
|
Wazza222
|
13K |
7.7M |
3 |
16/04/22 |
16/04/22 |
Charts
|
13K
|
7.7M
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
Wazza222
|
530 |
151K |
4 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
530
|
151K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
A timeline going forward would be greatly appreciated
|
|
Wazza222
|
138 |
53K |
8 |
20/03/22 |
20/03/22 |
ASX - By Stock
|
138
|
53K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
A timeline going forward would be greatly appreciated
|
|
Wazza222
|
138 |
53K |
2 |
20/03/22 |
20/03/22 |
ASX - By Stock
|
138
|
53K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
A timeline going forward would be greatly appreciated
|
|
Wazza222
|
138 |
53K |
6 |
19/03/22 |
19/03/22 |
ASX - By Stock
|
138
|
53K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Wazza222
|
5.4K |
2.7M |
17 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Wazza222
|
115 |
41K |
4 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
115
|
41K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Wazza222
|
115 |
41K |
3 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
115
|
41K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Wazza222
|
115 |
41K |
8 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
115
|
41K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Wazza222
|
115 |
41K |
2 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
115
|
41K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Wazza222
|
115 |
41K |
18 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
115
|
41K
|
18
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Wazza222
|
115 |
41K |
17 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
115
|
41K
|
17
|
|
ASX - By Stock
|
AVR |
Re:
CRT 2022 Award Nomination
|
|
Wazza222
|
7 |
2.6K |
0 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
7
|
2.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
CRT 2022 Award Nomination
|
|
Wazza222
|
7 |
2.6K |
1 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
7
|
2.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
CRT 2022 Award Nomination
|
|
Wazza222
|
7 |
2.6K |
9 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
7
|
2.6K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Merger Proposal Update
|
|
Wazza222
|
28 |
9.0K |
29 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
28
|
9.0K
|
29
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
Wazza222
|
141 |
45K |
3 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
141
|
45K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Wazza222
|
115 |
45K |
4 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
115
|
45K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Wazza222
|
4.7K |
1.1M |
1 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Wazza222
|
4.7K |
1.1M |
7 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
7
|
|
ASX - By Stock
|
LI8 |
Re:
Ann: Master Trust Deed
|
|
Wazza222
|
1 |
370 |
0 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
1
|
370
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
Wazza222
|
124 |
38K |
7 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
124
|
38K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
TCT conference starts tomorrow
|
|
Wazza222
|
34 |
8.5K |
1 |
07/11/21 |
07/11/21 |
ASX - By Stock
|
34
|
8.5K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
TCT conference starts tomorrow
|
|
Wazza222
|
34 |
8.5K |
1 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
34
|
8.5K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
TCT conference starts tomorrow
|
|
Wazza222
|
34 |
8.5K |
0 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
34
|
8.5K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Chief Medical Officer Appointment
|
|
Wazza222
|
41 |
12K |
3 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
41
|
12K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
2 |
12/09/21 |
12/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
Wazza222
|
104 |
44K |
5 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
104
|
44K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
Wazza222
|
104 |
44K |
0 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
104
|
44K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Wazza222
|
17K |
6.7M |
14 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
14
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Wazza222
|
10K |
3.0M |
3 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR presentation at the TVT 2021 Innovation session
|
|
Wazza222
|
19 |
6.6K |
1 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
19
|
6.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
Wazza222
|
20 |
6.9K |
0 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
20
|
6.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
Wazza222
|
49 |
13K |
0 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
49
|
13K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
Wazza222
|
49 |
13K |
4 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
49
|
13K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Wazza222
|
114 |
27K |
1 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
114
|
27K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
LYC Drop
|
|
Wazza222
|
219 |
99K |
1 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
219
|
99K
|
1
|
|